Predicting adverse events in children with fever and chemotherapy-induced neutropenia: The prospective multicenter SPOG 2003 FN study

Journal of Clinical Oncology

Volumn 28, Issue 12, 2010, Pages 2008-2014

  Ammann, Roland A ^a   Bodmer, Nicole ^a   Hirt, Andreas ^a   Niggli, Felix K ^a   Nadal, David ^a   Simon, Arne ^a   Ozsahin, Hulya ^a   Kontny, Udo ^a   Kühne, Thomas ^a   Beck Popovic, Maja ^a   Lüthy, Annette Ridolfi ^a   Aebi, Christoph ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTINEOPLASTIC AGENT; CIPROFLOXACIN; HEMOGLOBIN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; BACTEREMIA; CANCER CHEMOTHERAPY; CANCER RELAPSE; CENTRAL NERVOUS SYSTEM TUMOR; CHILD; CLINICAL TRIAL; DRUG FEVER; FEMALE; GRAM NEGATIVE INFECTION; GRAM POSITIVE INFECTION; HUMAN; INFANT; LEUKOCYTE COUNT; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MULTICENTER STUDY; MYCOSIS; NEUTROPENIA; PNEUMONIA; PREDICTION; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD; SCORING SYSTEM; SENSITIVITY ANALYSIS; SOLID TUMOR; THROMBOCYTE COUNT; VIRUS INFECTION; BLOOD; CHEMICALLY INDUCED DISORDER; EVALUATION; FEVER; GERMANY; HOSPITALIZATION; METABOLISM; PREDICTION AND FORECASTING; PROGNOSIS; PROSPECTIVE STUDY; REPRODUCIBILITY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; STATISTICAL MODEL; SWITZERLAND;

ANTINEOPLASTIC AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; FEVER; GERMANY; HEMOGLOBINS; HUMANS; LEUKOCYTE COUNT; LOGISTIC MODELS; MALE; NEUTROPENIA; PLATELET COUNT; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SWITZERLAND;

EID: 77951637541     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2009.25.8988     Document Type: Article

References (37)

1. Bodey GP, Buckley M, Sathe YS, et al: Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 64:328-340, 1966
2. Talcott JA, Siegel RD, Finberg R, et al: Risk assessment in cancer patients with fever and neutropenia: A prospective, two-center validation of a prediction rule. J Clin Oncol 10:316-322, 1992
3. Klastersky J, Paesmans M, Rubenstein EB, et al: The Multinational Association for Supportive Care in Cancer risk index: A multinational scoring system for identifying low-risk febrile neutropenic cancer patients. J Clin Oncol 18:3038-3051, 2000 (Pubitemid 30644129)
4. Hughes WT, Armstrong D, Bodey GP, et al: 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 34:730-751, 2002
5. Hann I, Viscoli C, Paesmans M, et al: A comparison of outcome from febrile neutropenic episodes in children compared with adults: Results from four EORTC studies. Br J Haematol 99:580-588, 1997 (Pubitemid 27519860)
6. Rackoff WR, Gonin R, Robinson C, et al: Predicting the risk of bacteremia in children with fever and neutropenia. J Clin Oncol 14:919-924, 1996 (Pubitemid 26085537)
7. Klaassen RJ, Goodman TR, Pham B, et al: "Low-risk" prediction rule for pediatric oncology patients presenting with fever and neutropenia. J Clin Oncol 18:1012-1019, 2000 (Pubitemid 30123777)
8. Santolaya ME, Alvarez AM, Becker A, et al: Prospective, multicenter evaluation of risk factors associated with invasive bacterial infection in children with cancer, neutropenia, and fever. J Clin Oncol 19:3415-3421, 2001 (Pubitemid 32642195)
9. Santolaya ME, Alvarez AM, Avilés CL, et al: Prospective evaluation of a model of prediction of invasive bacterial infection risk among children with cancer, fever, and neutropenia. Clin Infect Dis 35:678-683, 2002 (Pubitemid 35024727)
10. Holdsworth M, Hanrahan J, Albanese B, et al: Outpatient management of febrile neutropenia in children with cancer. Paediatr Drugs 5:443-455, 2003 (Pubitemid 36976115)
11. Ammann RA, Simon A, de Bont ESJM: Low risk episodes of fever and neutropenia in pediatric oncology: Is outpatient oral antibiotic therapy the new gold standard of care? Pediatr Blood Cancer 45:244-247, 2005
12. Härtel C, Deuster M, Lehrnbecher T, et al: Current approaches for risk stratification of infectious complications in pediatric oncology. Pediatr Blood Cancer 49:767-773, 2007 (Pubitemid 47519510)
13. Paulus S, Dobson S: Febrile neutropenia in children with cancer. Adv Exp Med Biol 634:185-204, 2009
14. te Poele EM, Tissing WJE, Kamps WA, et al: Risk assessment in fever and neutropenia in children with cancer: What did we learn? Crit Rev Oncol Hematol 72:45-55, 2009
15. Oude Nijhuis C, Kamps WA, Daenen SMG, et al: Feasibility of withholding antibiotics in selected febrile neutropenic cancer patients. J Clin Oncol 23:7437-7444, 2005 (Pubitemid 46291805)
16. Boragina M, Patel H, Reiter S, et al: Management of febrile neutropenia in pediatric oncology patients: A Canadian survey. Pediatr Blood Cancer 48:521-526, 2007 (Pubitemid 46496346)
17. Phillips B, Selwood K, Lane SM, et al: Variation in policies for the management of febrile neutropenia in United Kingdom Children's Cancer Study Group centers. Arch Dis Child 92:495-498, 2007 (Pubitemid 46867264)
18. Lucas KG, Brown AE, Armstrong D, et al: The identification of febrile, neutropenic children with neoplastic disease at low risk for bacteremia and complications of sepsis. Cancer 77:791-798, 1996 (Pubitemid 26055407)
19. Baorto EP, Aquino VM, Mullen CA, et al: Clinical parameters associated with low bacteremia risk in 1001 pediatric oncology patients with fever and neutropenia. Cancer 92:909-913, 2001 (Pubitemid 32783080)
20. Walsh TJ, Roilides E, Groll AH, et al: Infectious complications in pediatric cancer patients, in Pizzo PA, Poplack DG (eds): Principles and Practice of Pediatric Oncology (ed 5). Philadelphia, PA, Lippincott Williams & Wilkins, 2006, pp 1269-1329
21. Feld R: Criteria for response in patients in clinical trials of empiric antibiotic regimens for febrile neutropenia: Is there agreement? Support Care Cancer 6:444-448, 1998
22. Alexander SW, Wade KC, Hibberd PL, et al: Evaluation of risk prediction criteria for episodes of febrile neutropenia in children with cancer. J Pediatr Hematol Oncol 24:38-42, 2002 (Pubitemid 34094328)
23. Brown H, Prescott R: Applied Mixed Models in Medicine (ed 2). Chichester, United Kingdom, Wiley, 2006
24. Zhang H, Singer B: Recursive Partitioning in the Health Sciences. New York, NY, Springer, 1999
25. Altman DG: Practical Statistics for Medical Research. London, United Kingdom, Chapman & Hall, 1991
26. Pepe MS: The Statistical Evaluation of Medical Tests for Classification and Prediction. Oxford, United Kingdom, Oxford University Press, 2003
27. Goldstein B, Giroir B, Randolph A, et al: International pediatric sepsis consensus conference: Definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med 6:2-8, 2005
28. Aquino VM, Herrera L, Sandler ES, et al: Feasibility of oral ciprofloxacin for the outpatient management of febrile neutropenia in selected children with cancer. Cancer 88:1710-1714, 2000 (Pubitemid 30183158)
29. Petrilli AS, Dantas LS, Campos MC, et al: Oral ciprofloxacin vs. intravenous ceftriaxone administered in an outpatient setting for fever and neutropenia in low-risk pediatric oncology patients: Randomized prospective trial. Med Pediatr Oncol 34:87-91, 2000 (Pubitemid 30090470)
30. Ammann RA, Hirt A, Ridolfi Lüthy A, et al: Identification of children presenting with fever in chemotherapy- induced neutropenia at low risk for severe bacterial infection. Med Pediatr Oncol 41:436-443, 2003 (Pubitemid 37229435)
31. Rondinelli PIP, de Cassia Braga Ribeiro K, de Camargo B: A proposed score for predicting severe infection complications in children with chemotherapy- induced febrile neutropenia. J Pediatr Hematol Oncol 28:665-670, 2006 (Pubitemid 44540164)
32. Ammann RA, Hirt A, Ridolfi Lüthy A, et al: Predicting bacteremia in children with fever and chemotherapy-induced neutropenia. Pediatr Infect Dis J 23:61-67, 2004 (Pubitemid 38176764)
33. Mullen CA, Petropoulos D, Roberts WM, et al: Outpatient treatment of fever and neutropenia for low risk pediatric cancer patients. Cancer 86:126-134, 1999 (Pubitemid 29293385)
34. Santolaya ME, Alvarez AM, Aviles CL, et al: Predictors of severe sepsis not clinically apparent during the first twenty-four hours of hospitalization in children with cancer, neutropenia, and fever. Pediatr Infect Dis J 27:538-543, 2008
35. Paganini H, Gomez S, Ruvinsky S, et al: Outpatient, sequential, parenteral-oral antibiotic therapy for lower risk febrile neutropenia in children with malignant disease. Cancer 97:1775-1780, 2003 (Pubitemid 36350721)
36. Park JR, Coughlin J, Hawkins D, et al: Ciprofloxacin and amoxicillin as continuation treatment of febrile neutropenia in pediatric cancer patients. Med Pediatr Oncol 40:93-98, 2003 (Pubitemid 35471372)
37. Steiner I, Aebi C, Ridolfi Lüthy A, et al: Fatal adenovirus hepatitis during maintenance therapy for childhood acute lymphoblastic leukemia. Pediatr Blood Cancer 50:647-649, 2008 (Pubitemid 351155846)